Thyrocare Technologies Limited — Regulatory Filings 2021

Jan 14, 2021

ocare[®] Thyr Think Thyroid. Think Thyrocare.

==> picture [43 x 354] intentionally omitted <==

==> picture [25 x 456] intentionally omitted <==

January 13, 2021

National Stock Exchange ofl ndia Limited Exchange Plaza Sandra Kurla Complex, Bandra (E), Mumbai - 400 051 Symbol: THYROCARE

BSE Limited Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001 Scrip Code: 539871

Dear Sir/Madam,

Sub: Submission of Certificate under Regulation 74 (5) of the SEBT (epositories and Participants) Regulations, 2018 for the Quarter ended December 3 I, 2020

Pursuant to the provisions of Regulation 74 (5) of the Security and Exchange Board of India (Depositories and Participants) Regulations, 20 I 8, we are forwarding herewith a copy of ce,tificate dated 13[th ] January, 202I issued by our Registrar and Share Transfer Agent, Link Jntime India Private Limited, for the quaiter ended December 3 l, 2020.

This is for your information and records.

Yours Faithfully,

For Thyrocare Technologies Limited,

==> picture [83 x 81] intentionally omitted <==

==> picture [80 x 41] intentionally omitted <==

Ramjee Dorai Company Secretary and Compliance Officer

Thyrocare Technologies Limited 9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai -400 7 03, India © 022- 3090 0000/ 4125 2525 � enquiry@thyrocare.com (® www.thyrocare.com

(CIN: L85110MH2000PLC123882)